News: Clostridium dificile diarrhea linked to maternal deaths and stillbirths

Article

In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat.

In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat, according to a report published in the June issue of the American Journal of Obstetrics and Gynecology.

Nadine G. Rouphael, MD, of the Centers for Disease Control and Prevention in Atlanta, and colleagues collected clinical and pathology data on severe cases and surveyed 798 infectious disease consultants in the Emerging Infections Network, of whom 419 (52%) responded.

The researchers collected information on 10 severe cases, including three maternal deaths and three stillbirths. In two cases, the epidemic C difficile strain was identified. In their survey, 37 infectious disease consultants cited a total of 55 cases and 21 complications, most of which occurred during the postpartum period.

Rouphael NG, O'Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008:198:635.e1-635.e6.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.